Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.2250
+0.0150 (7.14%)
Jun 19, 2026, 10:39 AM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 126.08 million as of June 18, 2026. Its market cap has decreased by -62.53% in one year.
Market Cap
126.08M
Enterprise Value
87.63M
Revenue
7.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 126.08M, an increase of 852.55%. That is a compound annual growth rate of 22.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 114.08M | -65.45% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 209.64M |
| Recce Pharmaceuticals | 147.48M |
| Alterity Therapeutics | 125.07M |
| Actinogen Medical | 117.05M |
| Nyrada | 112.68M |
| Island Pharmaceuticals | 109.49M |
| Paradigm Biopharmaceuticals | 94.58M |
| LTR Pharma | 92.71M |